ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Carbapenem-Based Antibiotics Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33O10379
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Carbapenem Based Antibiotics Market Research Report 2022
BUY CHAPTERS

Global Carbapenem-Based Antibiotics Market Research Report 2025

Code: QYRE-Auto-33O10379
Report
March 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ACS Dobfar
Daewoong Pharmaceutical Co Ltd
Aurobindo Pharma Ltd.
Gland Pharma Limited
Merck& Co. Inc
Sumitomo Dainippon Pharma Co Ltd
Savior Lifetec
Pfizer Inc
Spero Therapeutics
Iterum Therapeutics plc

Carbapenem-Based Antibiotics Market

The global market for Carbapenem-Based Antibiotics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Carbapenem-Based Antibiotics in Retail Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Carbapenem-Based Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem-Based Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-Based Antibiotics.
The Carbapenem-Based Antibiotics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Carbapenem-Based Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem-Based Antibiotics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Carbapenem-Based Antibiotics Market Report

Report Metric Details
Report Name Carbapenem-Based Antibiotics Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Carbapenem-Based Antibiotics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Carbapenem-Based Antibiotics Market report?

Ans: The main players in the Carbapenem-Based Antibiotics Market are ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics

What are the Application segmentation covered in the Carbapenem-Based Antibiotics Market report?

Ans: The Applications covered in the Carbapenem-Based Antibiotics Market report are Retail Pharmacies, Online Pharmacies, Hospital Pharmacies

What are the Type segmentation covered in the Carbapenem-Based Antibiotics Market report?

Ans: The Types covered in the Carbapenem-Based Antibiotics Market report are Meropenem, Doripenemu, Imipenem, Tebipenemu, Others

Recommended Reports

Carbapenem Antibiotics

Broader Antibiotics Market

Antibiotic Resistance & API

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Meropenem
1.2.3 Doripenemu
1.2.4 Imipenem
1.2.5 Tebipenemu
1.2.6 Others
1.3 Market by Application
1.3.1 Global Carbapenem-Based Antibiotics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.3.4 Hospital Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carbapenem-Based Antibiotics Market Perspective (2020-2031)
2.2 Global Carbapenem-Based Antibiotics Growth Trends by Region
2.2.1 Global Carbapenem-Based Antibiotics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Carbapenem-Based Antibiotics Historic Market Size by Region (2020-2025)
2.2.3 Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031)
2.3 Carbapenem-Based Antibiotics Market Dynamics
2.3.1 Carbapenem-Based Antibiotics Industry Trends
2.3.2 Carbapenem-Based Antibiotics Market Drivers
2.3.3 Carbapenem-Based Antibiotics Market Challenges
2.3.4 Carbapenem-Based Antibiotics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carbapenem-Based Antibiotics Players by Revenue
3.1.1 Global Top Carbapenem-Based Antibiotics Players by Revenue (2020-2025)
3.1.2 Global Carbapenem-Based Antibiotics Revenue Market Share by Players (2020-2025)
3.2 Global Carbapenem-Based Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Carbapenem-Based Antibiotics Revenue
3.4 Global Carbapenem-Based Antibiotics Market Concentration Ratio
3.4.1 Global Carbapenem-Based Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carbapenem-Based Antibiotics Revenue in 2024
3.5 Global Key Players of Carbapenem-Based Antibiotics Head office and Area Served
3.6 Global Key Players of Carbapenem-Based Antibiotics, Product and Application
3.7 Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Carbapenem-Based Antibiotics Breakdown Data by Type
4.1 Global Carbapenem-Based Antibiotics Historic Market Size by Type (2020-2025)
4.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031)
5 Carbapenem-Based Antibiotics Breakdown Data by Application
5.1 Global Carbapenem-Based Antibiotics Historic Market Size by Application (2020-2025)
5.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Carbapenem-Based Antibiotics Market Size (2020-2031)
6.2 North America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
6.4 North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carbapenem-Based Antibiotics Market Size (2020-2031)
7.2 Europe Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
7.4 Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carbapenem-Based Antibiotics Market Size (2020-2031)
8.2 Asia-Pacific Carbapenem-Based Antibiotics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025)
8.4 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carbapenem-Based Antibiotics Market Size (2020-2031)
9.2 Latin America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
9.4 Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carbapenem-Based Antibiotics Market Size (2020-2031)
10.2 Middle East & Africa Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
10.4 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACS Dobfar S.p.A
11.1.1 ACS Dobfar S.p.A Company Details
11.1.2 ACS Dobfar S.p.A Business Overview
11.1.3 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Introduction
11.1.4 ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.1.5 ACS Dobfar S.p.A Recent Development
11.2 Iterum Therapeutics plc
11.2.1 Iterum Therapeutics plc Company Details
11.2.2 Iterum Therapeutics plc Business Overview
11.2.3 Iterum Therapeutics plc Carbapenem-Based Antibiotics Introduction
11.2.4 Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.2.5 Iterum Therapeutics plc Recent Development
11.3 DAEWOONG PHARMACEUTICAL CO.,LTD
11.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Details
11.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
11.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Introduction
11.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
11.4 Aurobindo Pharma Ltd
11.4.1 Aurobindo Pharma Ltd Company Details
11.4.2 Aurobindo Pharma Ltd Business Overview
11.4.3 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Introduction
11.4.4 Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.4.5 Aurobindo Pharma Ltd Recent Development
11.5 Gland Pharma Limited
11.5.1 Gland Pharma Limited Company Details
11.5.2 Gland Pharma Limited Business Overview
11.5.3 Gland Pharma Limited Carbapenem-Based Antibiotics Introduction
11.5.4 Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.5.5 Gland Pharma Limited Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Carbapenem-Based Antibiotics Introduction
11.6.4 Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd.
11.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development
11.8 Savior Lifetec
11.8.1 Savior Lifetec Company Details
11.8.2 Savior Lifetec Business Overview
11.8.3 Savior Lifetec Carbapenem-Based Antibiotics Introduction
11.8.4 Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.8.5 Savior Lifetec Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Carbapenem-Based Antibiotics Introduction
11.9.4 Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.9.5 Pfizer Inc. Recent Development
11.10 Spero Therapeutics
11.10.1 Spero Therapeutics Company Details
11.10.2 Spero Therapeutics Business Overview
11.10.3 Spero Therapeutics Carbapenem-Based Antibiotics Introduction
11.10.4 Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.10.5 Spero Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ACS Dobfar
Daewoong Pharmaceutical Co Ltd
Aurobindo Pharma Ltd.
Gland Pharma Limited
Merck& Co. Inc
Sumitomo Dainippon Pharma Co Ltd
Savior Lifetec
Pfizer Inc
Spero Therapeutics
Iterum Therapeutics plc
List of Tables
 Table 1. Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Meropenem
 Table 3. Key Players of Doripenemu
 Table 4. Key Players of Imipenem
 Table 5. Key Players of Tebipenemu
 Table 6. Key Players of Others
 Table 7. Global Carbapenem-Based Antibiotics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Carbapenem-Based Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Carbapenem-Based Antibiotics Market Share by Region (2020-2025)
 Table 11. Global Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Carbapenem-Based Antibiotics Market Share by Region (2026-2031)
 Table 13. Carbapenem-Based Antibiotics Market Trends
 Table 14. Carbapenem-Based Antibiotics Market Drivers
 Table 15. Carbapenem-Based Antibiotics Market Challenges
 Table 16. Carbapenem-Based Antibiotics Market Restraints
 Table 17. Global Carbapenem-Based Antibiotics Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Carbapenem-Based Antibiotics Market Share by Players (2020-2025)
 Table 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)
 Table 20. Ranking of Global Top Carbapenem-Based Antibiotics Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Carbapenem-Based Antibiotics Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Carbapenem-Based Antibiotics, Headquarters and Area Served
 Table 23. Global Key Players of Carbapenem-Based Antibiotics, Product and Application
 Table 24. Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Carbapenem-Based Antibiotics Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2020-2025)
 Table 28. Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2026-2031)
 Table 30. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2020-2025)
 Table 32. Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2026-2031)
 Table 34. North America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Carbapenem-Based Antibiotics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
 Table 49. ACS Dobfar S.p.A Company Details
 Table 50. ACS Dobfar S.p.A Business Overview
 Table 51. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Product
 Table 52. ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 53. ACS Dobfar S.p.A Recent Development
 Table 54. Iterum Therapeutics plc Company Details
 Table 55. Iterum Therapeutics plc Business Overview
 Table 56. Iterum Therapeutics plc Carbapenem-Based Antibiotics Product
 Table 57. Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 58. Iterum Therapeutics plc Recent Development
 Table 59. DAEWOONG PHARMACEUTICAL CO.,LTD Company Details
 Table 60. DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
 Table 61. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Product
 Table 62. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 63. DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
 Table 64. Aurobindo Pharma Ltd Company Details
 Table 65. Aurobindo Pharma Ltd Business Overview
 Table 66. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Product
 Table 67. Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 68. Aurobindo Pharma Ltd Recent Development
 Table 69. Gland Pharma Limited Company Details
 Table 70. Gland Pharma Limited Business Overview
 Table 71. Gland Pharma Limited Carbapenem-Based Antibiotics Product
 Table 72. Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 73. Gland Pharma Limited Recent Development
 Table 74. Merck & Co., Inc. Company Details
 Table 75. Merck & Co., Inc. Business Overview
 Table 76. Merck & Co., Inc. Carbapenem-Based Antibiotics Product
 Table 77. Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 78. Merck & Co., Inc. Recent Development
 Table 79. Sumitomo Dainippon Pharma Co., Ltd. Company Details
 Table 80. Sumitomo Dainippon Pharma Co., Ltd. Business Overview
 Table 81. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Product
 Table 82. Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 83. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
 Table 84. Savior Lifetec Company Details
 Table 85. Savior Lifetec Business Overview
 Table 86. Savior Lifetec Carbapenem-Based Antibiotics Product
 Table 87. Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 88. Savior Lifetec Recent Development
 Table 89. Pfizer Inc. Company Details
 Table 90. Pfizer Inc. Business Overview
 Table 91. Pfizer Inc. Carbapenem-Based Antibiotics Product
 Table 92. Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 93. Pfizer Inc. Recent Development
 Table 94. Spero Therapeutics Company Details
 Table 95. Spero Therapeutics Business Overview
 Table 96. Spero Therapeutics Carbapenem-Based Antibiotics Product
 Table 97. Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
 Table 98. Spero Therapeutics Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. Carbapenem-Based Antibiotics Picture
 Figure 2. Global Carbapenem-Based Antibiotics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Carbapenem-Based Antibiotics Market Share by Type: 2024 VS 2031
 Figure 4. Meropenem Features
 Figure 5. Doripenemu Features
 Figure 6. Imipenem Features
 Figure 7. Tebipenemu Features
 Figure 8. Others Features
 Figure 9. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Carbapenem-Based Antibiotics Market Share by Application: 2024 VS 2031
 Figure 11. Retail Pharmacies Case Studies
 Figure 12. Online Pharmacies Case Studies
 Figure 13. Hospital Pharmacies Case Studies
 Figure 14. Carbapenem-Based Antibiotics Report Years Considered
 Figure 15. Global Carbapenem-Based Antibiotics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Carbapenem-Based Antibiotics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Carbapenem-Based Antibiotics Market Share by Region: 2024 VS 2031
 Figure 18. Global Carbapenem-Based Antibiotics Market Share by Players in 2024
 Figure 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Carbapenem-Based Antibiotics Revenue in 2024
 Figure 21. North America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
 Figure 23. United States Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
 Figure 27. Germany Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Carbapenem-Based Antibiotics Market Share by Region (2020-2031)
 Figure 35. China Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
 Figure 43. Mexico Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
 Figure 47. Turkey Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. ACS Dobfar S.p.A Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 51. Iterum Therapeutics plc Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 52. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 53. Aurobindo Pharma Ltd Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 54. Gland Pharma Limited Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 55. Merck & Co., Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 56. Sumitomo Dainippon Pharma Co., Ltd. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 57. Savior Lifetec Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 58. Pfizer Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 59. Spero Therapeutics Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Carbapenem API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ampicillin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Broad spectrum Antibiotics Market Research Report 2025
Cephalosporin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cephalosporin Antibiotics Market Research Report 2024
Global Alternative to Antibiotics Market Research Report 2024
Multidrug Resistant Bacteria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibiotic Stopper Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Antibiotics Market Research Report 2025
Global Carbapenemase producing Assay Kit Market Research Report 2025
Gram Negative lnfections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Semi Synthetic Penicillin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibiotic Resistance Market Insights Forecast to 2030
Global Carbapenem Market Insights Forecast to 2030
Global Carbapenem Drugs Market Research Report 2024
Antimicrobial Gauze Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Quinolones Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ceftazidime for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Synthetic Penicillin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Antibiotic Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions